Also known as: Hashish in 19th century literature · Cannabis and the Romantic writers

Cannabis in 19th Century Literature

European and American writers documented cannabis through clinical observation, exotic fantasy, and moral caution.

Automated fact-check pass
8 cited sources
Published
Last reviewed
How this page was made
↯ The honest take

The 19th-century writers gave us vivid, pharmacologically plausible accounts of high-dose oral cannabis. But they also established Orientalist myths—that cannabis is an 'Eastern vice,' that it unlocks artistic genius—that shaped prohibition rhetoric for a century. Baudelaire didn't champion cannabis; he condemned it. Quoting him on a product label is marketing, not history.

Cannabis enters European awareness

European knowledge of cannabis as an intoxicant expanded sharply following Napoleon's 1798–1801 Egyptian campaign. French soldiers encountered hashish in Egypt and North Africa and brought samples and accounts back to Europe. The earliest regulatory response came from within the military: in 1800, a French army order reportedly restricted soldiers' consumption of hashish Weak / limited. The primary source for this order remains unclear; most references cite Martin Booth's popular history rather than an archived French military document.

The first systematic European study came from Jacques-Joseph Moreau de Tours, a Parisian psychiatrist who studied hashish consumption in North Africa and published Du hachisch et de l'aliénation mentale in 1845 [1]. Moreau's work was pioneering: he argued that hashish produced a temporary state resembling mental illness and could therefore serve as a research tool for understanding psychosis. This was the first major psychiatric hypothesis linking a drug to psychopathology, grounded in careful clinical observation Strong evidence[1]. Moreau supplied hashish to the Parisian literary circle that would become known as the Club des Hashischins.

The Club des Hashischins

From approximately 1844 to 1849, a group of Parisian writers and artists gathered regularly at the Hôtel Pimodan on the Île Saint-Louis to consume dawamesk—a green paste made from hashish, pistachio, sugar, orange juice, and spices [2][3]. Members and visitors included the poet Théophile Gautier, the writer Charles Baudelaire, the painter Eugène Delacroix, and the novelists Gérard de Nerval, Honoré de Balzac, and Alexandre Dumas [2][3].

Théophile Gautier's essay Le Club des Hachichins, published in Revue des Deux Mondes in February 1846, is the most detailed surviving account of a dawamesk session [3]. Gautier described hallucinations of elongating limbs, uncontrollable laughter, and geometric visions—effects consistent with high-dose oral cannabis. The doses were substantial; dawamesk was not a light or social drug Strong evidence. This distinction matters when interpreting 19th-century literature: the sensations described derive from pharmacologically intensive oral administration, not from typical modern flower smoking.

Honoré de Balzac is reported to have attended the club but claimed he refused to eat the paste, preferring to observe the others Anecdote[2]. Later claims that Balzac was a regular participant lack direct support from Balzac's own letters or published accounts.

Baudelaire's moral verdict

Charles Baudelaire authored the era's most influential cannabis text: Les Paradis artificiels (1860), which includes an extended section titled Le Poème du hachisch [4]. Despite Baudelaire's participation in the Club, his conclusion was harshly moralistic. He characterized hashish as offering a counterfeit, willless paradise and argued that the true artist must reject it in favor of disciplined imagination and reason [4]. Baudelaire was an ambivalent chronicler, not a champion Strong evidence[4].

This distinction is historically important because Baudelaire is frequently cited in modern cannabis marketing as an advocate for the drug. Contemporary sources commonly quote selected passages—particularly his vivid descriptions of sensory intensity—while omitting his explicit moral condemnation. The resulting image of Baudelaire as a cannabis enthusiast is a selective misreading that has persisted into the 21st century Strong evidence.

American hashish writing: Ludlow and the pharmaceutical era

In the United States, the defining work was Fitz Hugh Ludlow's The Hasheesh Eater: Being Passages from the Life of a Pythagorean (1857), written when Ludlow was in his early twenties. Ludlow was a student in Poughkeepsie, New York, who obtained Tilden's Extract—a cannabis tincture legally sold by Tilden & Co. as a pharmaceutical remedy—from a local druggist. Cannabis tinctures were widely available in 19th-century American and British pharmacies as treatments for pain, convulsions, and other ailments.

Ludlow's book is openly modeled on Thomas De Quincey's Confessions of an English Opium-Eater (1821) and describes escalating tolerance to the tincture, terrifying hallucinations, and a difficult period of discontinuation. Ludlow's account stands among the first detailed English-language descriptions of tolerance and withdrawal-like symptoms from high-dose oral cannabis use, though comparable medical reports exist in O'Shaughnessy's work (see below) Weak / limited.

Other American writers framed hashish as an Orientalist adventure. Bayard Taylor, who traveled in the Middle East and published The Lands of the Saracen (1855) and essays in Putnam's Magazine, presented hashish consumption as an exotic foreign experience rather than as a subject for moral or medical scrutiny [5]. This Orientalist trope—hashish as inherently 'Eastern'—would shape American and European prohibition rhetoric well into the 20th century Strong evidence.

British medicine and colonial inquiry

British engagement with cannabis in the 19th century was driven primarily by colonial medicine and imperial administration rather than by literary circles. William Brooke O'Shaughnessy, an Irish physician working in Calcutta, published On the Preparations of the Indian Hemp, or Gunjah in the Provincial Medical Journal in 1843, introducing cannabis to Western medicine as a treatment for tetanus, rheumatism, convulsions, and other conditions [6]. O'Shaughnessy's paper triggered decades of cannabis tinctures in British and American pharmacopoeias and represented the first major medical endorsement of cannabis in European medicine Strong evidence[6].

The Indian Hemp Drugs Commission Report (1894), commissioned by the British colonial government in India, remains the largest primary source document of the 19th century on cannabis use. Spanning seven volumes and drawing testimony from over 1,000 witnesses across India, the report concluded that moderate cannabis use was largely harmless and that prohibition was impractical [7]. This conclusion is cited frequently in modern cannabis policy discussions, sometimes with more confidence than the report's own language warrants. The report did note risks associated with heavy use and acknowledged regional variation in consumption patterns and social outcomes Strong evidence[7].

British fiction of the period, including works by Arthur Conan Doyle and other late-Victorian writers, generally treated cannabis as an exotic Eastern signifier rather than as a serious subject for literary treatment or moral examination.

What 19th-century accounts got right—and the myths they created

Pharmacologically accurate observations:

The 19th-century writers—particularly Moreau, Gautier, and Ludlow—documented effects consistent with modern understanding of cannabis: time distortion, increased appetite, laughter, dose-dependent anxiety, and next-day cognitive fog Strong evidence. These reports validate that the drug's effects have remained pharmacologically stable across two centuries.

Myths and distortions that emerged:

The 19th-century texts are best read as they are: literary experiments, colonial ethnography, and early clinical case observations. They are not a reliable guide to cannabis effects in contemporary users, and selective quotation of 19th-century writers for modern product marketing represents a misuse of historical sources.

Sources

How this page was made

Generation history

Nov 1, 2026
Fact-check pass — raised 9 flags
Nov 1, 2026
Revision
Nov 1, 2026
Fact-check pass — raised 8 flags
Aug 12, 2026
Fact-check pass — raised 3 flags
Aug 12, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.